Skip to main content
Rafee Talukder, MD, Oncology, Houston, TX

Rafee Talukder MD


Physician

Telehealth available

Request appointment
  • 18400 Katy FwySte 220Houston, TX 77094

  • Book by Phone+1(832) 612-3715

  • Fax+1 832-522-8624

Overview of  Dr. Talukder

Dr. Rafee Talukder is an oncologist based in Houston, TX, specializing in genitourinary oncology, melanoma, and sarcoma. He completed his residency in internal medicine at Baylor College of Medicine in 2019 and a fellowship in hematology and medical oncology at the University of Washington in 2023. Dr. Talukder has contributed to several publications, focusing on topics like immune checkpoint inhibitors in advanced urothelial carcinoma and genomic alterations. His work has been featured in journals such as Clinical Genitourinary Cancer, BJC Reports, and Targeted Oncology.

Education & Training

  • University of Washington
    University of WashingtonFellowship, Hematology and Medical Oncology, 2020 - 2023
  • Baylor College of Medicine
    Baylor College of MedicineResidency, Internal Medicine, 2016 - 2019
  • The University of Texas Health Science Center at San Antonio
    The University of Texas Health Science Center at San AntonioClass of 2016

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2018 - 2028
  • SD State Medical License
    SD State Medical License Active through 2027
  • WA State Medical License
    WA State Medical License 2022 - 2024
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Differential Induction Among Younger Patients Diagnosed with Secondary Acute Myelogenous Leukemia Is Feasible By Cytogenetic/Molecular Risk Stratification
    Rafee Talukder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Superior Outcome in Elderly AML Patients Receiving Adjuvant Serotonin-Reuptake-Inhibitors during Induction 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Predictive Factors for Complete Remission and Survival in AML Patients Failing to Achieve Adequate Bone Marrow Day 14 Blast Eradication 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: